Michael Perkins Johnson - 12 Feb 2026 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Signature
/s/ Lily J. Lu, Attorney-in-Fact for Michael P. Johnson
Issuer symbol
IDXX
Transactions as of
12 Feb 2026
Net transactions value
-$112,024
Form type
4
Filing time
17 Feb 2026, 19:30:42 UTC
Previous filing
03 Jun 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Johnson Michael Perkins Executive Vice President ONE IDEXX DRIVE, WESTBROOK /s/ Lily J. Lu, Attorney-in-Fact for Michael P. Johnson 17 Feb 2026 0001917747

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $0 +176 +7.3% $0.000000 2,576 14 Feb 2026 Direct F1
transaction IDXX Common Stock Options Exercise $0 +179 +6.9% $0.000000 2,755 14 Feb 2026 Direct
transaction IDXX Common Stock Options Exercise $0 +218 +7.9% $0.000000 2,973 14 Feb 2026 Direct
transaction IDXX Common Stock Tax liability $112,024 -178 -6% $629.35 2,795 14 Feb 2026 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Non-Qualified Stock Option (right-to-buy) Award $0 +3,207 $0.000000 3,207 12 Feb 2026 Common Stock 3,207 $617.20 Direct F3
transaction IDXX Incentive Stock Option (right-to-buy) Award $0 +162 $0.000000 162 12 Feb 2026 Common Stock 162 $617.20 Direct F4
transaction IDXX Restricted Stock Unit Award $0 +770 $0.000000 770 12 Feb 2026 Common Stock 770 Direct F5
transaction IDXX Restricted Stock Unit Options Exercise $0 -176 -50% $0.000000 176 14 Feb 2026 Common Stock 176 Direct F6
transaction IDXX Restricted Stock Unit Options Exercise $0 -179 -33% $0.000000 356 14 Feb 2026 Common Stock 179 Direct F7
transaction IDXX Restricted Stock Unit Options Exercise $0 -218 -25% $0.000000 652 14 Feb 2026 Common Stock 218 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes a total of 34.345 shares purchased under the Issuer Employee Stock Purchase Plan ('ESPP') on June 30, 2025, September 30, 2025 and December 31, 2025. There are a total of 163.687 shares held in the ESPP which has been increased by 0.001 shares due to a rounding calculation of previously issued fractional shares.
F2 Closing price of Issuer common stock on Nasdaq Global Select Market on February 13, 2026.
F3 Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2027.
F4 Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2030.
F5 Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2027.
F6 Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2024.
F7 Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning on February 14, 2025.
F8 Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2026.